PEP/NEWS — Peptide intel. Daily.

Discover why a simple compound from tree pulp might outshine most modern prescription drugs for chronic pain and cellular repair. If you like this, please like, share, and subscribe! Follow The Spartan everywhere: Instagram: https://www.

Get LMNT Electrolytes & Receive a FREE Sample Flavors Pack: http://drinklmnt.com/thomas This video does contain a paid partnership with a brand that helps to support this channel. It is because of brands like this that we are able to provi

Try TrueDark glasses: https://truedark.com Try Danger Coffee: https://dangercoffee.com/discount/davetube Try Suppgrade Labs: https://shopsuppgradelabs.com/ This video walks you through the complete biological timeline of a 36-hour sugar fa

👉 Everything in this video is laid out step-by-step in my new book, Livingood Approved — get your free copy (plus the 100-recipe cookbook) here: https://dlgpromo.com/6c8bbf The reason most people can't lose fat and keep it off has nothing

Understanding how your home environment shapes your sexual development is key to healthy relationships. In this episode, Dr. Debra Durst sits down with New York Times best-selling author and AASECT-certified sex therapist Ian Kerner to unp

Part one of a three-part deep dive examines how cancer starts and which signaling pathways it exploits — many of which overlap with pathways that recovery and anti-aging peptides also act on. The biology here matters for any researcher thinking about risk context.

A new analysis found that short-term biological fluctuations — illness, acute stress, disrupted sleep — can skew methylation-based epigenetic clock readings. Researchers say clock outputs are generally reliable, but a single snapshot may mislead. That has direct implications for anyone using clocks to track intervention response.

Lifespan.io's July roundup covers the month's research wins and a high-profile treatment failure. It's a useful single-source overview of where the longevity field stands heading into Q3 2026 — including regulatory moves, new trial data, and community debate.

A new PLOS Biology study found that meal timing sets the circadian clock in the dorsal vagal complex — a brainstem region now recognized as a key target for GLP-1 class anti-obesity drugs. The finding suggests that when you eat may influence how well GLP-1 therapies perform.

Researchers found that blocking a mitochondrial transporter called SLC25A1 shuts down the inflammatory signaling that senescent cells pump out as they accumulate with age. The approach doesn't clear senescent cells — it silences them. That's a meaningful distinction for anyone following the senolytic space.

Stem cell-derived exosomes — tiny signaling particles — reduced post-heart attack inflammation and fibrosis in animal models, cutting scarring that normally leads to heart failure. The mechanism overlaps with pathways studied in peptide-mediated tissue repair, making it relevant context for recovery researchers.

The final installment of Research Vials' cancer series addresses the most contested question in GH secretagogue research: does elevated IGF-1 raise cancer risk? The piece walks through current evidence, the concept of washout periods, and how researchers are framing the risk-benefit question.

Activating GPR81 — a receptor that responds to lactate, the molecule produced during exercise — reduced hallmarks of cellular senescence and improved muscle function in aging cell and animal models. The finding draws a direct line between exercise-like metabolic signals and anti-aging biology.

A new Aging Cell paper asks how much of the variation in epigenetic clock outputs is biological versus measurement noise. The answer matters for anyone using clock data to evaluate whether an intervention is working.

Researchers found that diosgenin — a plant-derived compound — activated a known longevity pathway (SIRT1/PGC-1α) to stimulate muscle satellite cell activity and slow age-related muscle loss. The pathway is the same one targeted by several peptide and mitochondrial research programs.